Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
2
Early Signals Before Myeloma: Real-World Data Reveal Missed Opportunities for Earlier Diagnosis
3
GLP-1 Agonists May Favorably Influence Metabolic Risk and Breast Cancer Outcomes
4
FDA Approval of Zoliflodacin: A New Era in Gonorrhea Treatment
5